The FDA is aware that Boston Scientific has recommended the removal of unused Infinion CX leads due to 1,081 serious injuries reported. This indicates a significant product safety issue that could lead to financial and reputational damage for Boston Scientific.
Boston Scientific is facing a significant product safety issue with its Infinion CX leads, leading to 1,081 reported serious injuries. The FDA's awareness and Boston Scientific's recommendation to remove unused leads signal a serious recall. This event is highly negative for Boston Scientific, as it will likely incur costs associated with the recall, potential lawsuits, and damage to its brand reputation. In the short term, this could lead to a decline in BSX stock price. Long-term implications depend on how effectively Boston Scientific manages the recall and addresses the underlying issues, but it poses a significant risk to their market position in spinal cord stimulators.